More Testing Needed for PCa Patients, Study

Prostate cancer usually is slow growing, but some tumors can be aggressive and fatal. A process called genomic fingerprinting can be used to predict whether prostate cancer is likely to spread. According to a new study, more than one sample should be tested or a potentially aggressive tumor may be missed.

Prostate tumors can be genetically different—requiring different treatments—in the same patient. In some cases, molecular structure can vary even within the same tumor. Therefore, prostate cancer treatment plans developed using information from just one biopsy may not be the most effective.

Additional studies are needed. More and more research has shown that developing individualized treatment protocols for men with prostate cancer—and people with other types of cancer as well—may be the future of cancer treatment.

Image Credit: Thinkstock

Sourced from: ScienceDaily, One single biopsy not sufficient to guide treatment decisions in prostate cancer, say researchers